SG11202104785VA - Multivalent glycoconjugates immunogenic compositions - Google Patents
Multivalent glycoconjugates immunogenic compositionsInfo
- Publication number
- SG11202104785VA SG11202104785VA SG11202104785VA SG11202104785VA SG11202104785VA SG 11202104785V A SG11202104785V A SG 11202104785VA SG 11202104785V A SG11202104785V A SG 11202104785VA SG 11202104785V A SG11202104785V A SG 11202104785VA SG 11202104785V A SG11202104785V A SG 11202104785VA
- Authority
- SG
- Singapore
- Prior art keywords
- immunogenic compositions
- glycoconjugates
- multivalent
- multivalent glycoconjugates
- immunogenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201841017672 | 2018-11-10 | ||
PCT/IN2019/050825 WO2020095324A1 (en) | 2018-11-10 | 2019-11-07 | Multivalent glycoconjugates immunogenic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202104785VA true SG11202104785VA (en) | 2021-06-29 |
Family
ID=70610826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202104785VA SG11202104785VA (en) | 2018-11-10 | 2019-11-07 | Multivalent glycoconjugates immunogenic compositions |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210401960A1 (en) |
EP (1) | EP3876981A4 (en) |
KR (1) | KR20210092224A (en) |
CN (1) | CN113271967A (en) |
MX (1) | MX2021005500A (en) |
SG (1) | SG11202104785VA (en) |
WO (1) | WO2020095324A1 (en) |
ZA (1) | ZA202103644B (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR122012003821B8 (en) * | 2000-06-29 | 2021-05-25 | Glaxosmithkline Biologicals Sa | multivalent immunogenic composition, use thereof, and process to produce the immunogenic composition |
US20040258700A1 (en) * | 2003-06-23 | 2004-12-23 | Frimann Tine Holland | Vaccine formulation with a preservative |
GB201017519D0 (en) * | 2010-10-15 | 2010-12-01 | Novartis Vaccines Inst For Global Health S R L | Vaccines |
US9011871B2 (en) * | 2011-11-07 | 2015-04-21 | University Of Maryland, Baltimore | Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease |
US10046039B2 (en) * | 2013-08-24 | 2018-08-14 | Bharat Biotech International Limited | Bacterial vaccine and methods for manufacture thereof |
EP2870974A1 (en) * | 2013-11-08 | 2015-05-13 | Novartis AG | Salmonella conjugate vaccines |
-
2019
- 2019-11-07 US US17/292,024 patent/US20210401960A1/en active Pending
- 2019-11-07 CN CN201980088557.6A patent/CN113271967A/en active Pending
- 2019-11-07 WO PCT/IN2019/050825 patent/WO2020095324A1/en active Application Filing
- 2019-11-07 EP EP19881812.2A patent/EP3876981A4/en active Pending
- 2019-11-07 KR KR1020217016326A patent/KR20210092224A/en unknown
- 2019-11-07 MX MX2021005500A patent/MX2021005500A/en unknown
- 2019-11-07 SG SG11202104785VA patent/SG11202104785VA/en unknown
-
2021
- 2021-05-27 ZA ZA2021/03644A patent/ZA202103644B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20210401960A1 (en) | 2021-12-30 |
ZA202103644B (en) | 2022-03-30 |
EP3876981A1 (en) | 2021-09-15 |
EP3876981A4 (en) | 2022-11-02 |
WO2020095324A1 (en) | 2020-05-14 |
CN113271967A (en) | 2021-08-17 |
KR20210092224A (en) | 2021-07-23 |
MX2021005500A (en) | 2021-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL297575B1 (en) | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates | |
IL264552A (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
IL276229B1 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
ZA202202600B (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
IL264553A (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
SG11202010821TA (en) | Vaccine composition | |
GB201610599D0 (en) | Immunogenic Composition | |
GB201711635D0 (en) | Immunogenic composition | |
IL266080B (en) | Expec glycoconjugate vaccine formulations | |
GB201802339D0 (en) | Immunogenic composition | |
GB201711637D0 (en) | Immunogenic composition | |
IL284349A (en) | Multivalent pneumococcal polysaccharide-protein conjugate vaccine | |
IL264605A (en) | Multivalent vaccine composition | |
IL291559A (en) | Immunogenic compositions | |
GB201917699D0 (en) | Vaccine conjugates | |
SG11202009147UA (en) | Vaccine compositions | |
IL282753A (en) | Immunogenic composition | |
GB201614485D0 (en) | Immunogenic composition | |
IL279855A (en) | Improvements in immunogenic conjugates | |
IL271603A (en) | Immunogenic compositions | |
GB201604755D0 (en) | Immunogenic compositions | |
GB201803692D0 (en) | Immunogenic composition | |
ZA202103644B (en) | Multivalent glycoconjugates immunogenic compositions | |
GB201820010D0 (en) | Immunogenic composition | |
GB201807378D0 (en) | Vaccine composition |